fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.
GFI #213

It’s official: FDA implements GFI #213, paving way for new VFD rules

After years of planning, FDA said it has completed implementation of what it calls Guidance for Industry #213 — a process that requires antimicrobials with importance in human medicine to be used under veterinary oversight when added to the feed or drinking water of food-producing animals.

“The FDA can now report that, as of January 3, 2017, all affected drug applications have either aligned with the recommendations outlined in GFI #213, or their approvals have been voluntarily withdrawn,” the agency said in a statement.

“As a result of these changes, these products cannot be used for production (e.g., growth promotion) purposes and may only be used under the authorization of a licensed veterinarian.

The FDA noted the cooperation of the animal pharmaceutical industry for meeting its commitment to fully align all affected products with the GFI #213 recommendations. It also acknowledged the efforts of veterinary, animal producer and feed-industry organizations, as well as those of various local, state, and federal agencies.

“The success of this collaborative effort marks an important step forward for promoting antimicrobial stewardship in animals,” FDA added.

Of the 292 new animal drug applications initially affected by Guidance for Industry #213, 84 were completely withdrawn

Of the remaining 208 applications, 93 applications for oral dosage form products intended for use in water were converted from over-the-counter to prescription status. Another 115 applications for products intended for use in feed were converted from over-the-counter to veterinary feed directive status.

Production claims — e.g., improved feed conversion or weight gain —were withdrawn from all medically important antimicrobials that included such indications for use

For more information about the FDA’s goals and planned activities for promoting antimicrobial stewardship, see the FDA’s CVM Key Initiatives for Antimicrobial Stewardship.

More information is also available at Poultry Health Today’s VFD News Center and sister website, VFD News Center for Pork.





tags: , ,
RELATED NEWS



You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.